Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: g.w. barnard who wrote (7904)	5/7/1998 6:37:00 PM
From: VLAD	Respond to of 23519

g.w., Last I checked Zacks had Q2 at -.05 and First Call was at -.07. I think everyone expects poor numbers because of those trying out Viagra but based on the stock price I think the investment community sees things getting much better after Q2. Vivus was trading in the 7's when the Q2 estimates were positive and Viagra fear was at it's all time high. Now the Viagra hype is slowly wearing off, Vivus is done with its single digit days. If we close above 13 in the near future and the entire market doesn't undergo a massive correction then I expect a good old fashioned short squeeze to begin.